Modakafusp alfa (TAK-573) is an anti-CD38 ADC consisting of two attenuated IFNα2b molecules attached to an anti-CD38 IgG4 mAb that drives preferential IFNα signaling in myeloma cells [80]. The gene discussed is CD38; the disease is plasma cell myeloma.